https://orcid.org/0000-0001-6307-6369
References
- Scheidell JD, Pitre M, Andraka-Christou B. Racial and ethnic inequities in substance use treatment among women with opioid use disorder. Am J Drug Alcohol Abuse. 2024;50:106–16. doi:10.1080/00952990.2023.2291748.
- Khan MR, Hoff L, Elliott L, Scheidell JD, Pamplin JR, Townsend TN, Irvine NM, Bennett AS. Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City. Harm Reduct J. 2023;20:24. doi:10.1186/s12954-023-00736-7.
- Scheidell JD, Mahachi M, Elliott LC, Bennett AS. Racial/ethnic differences in sexual and reproductive health needs and receipt of services at syringe service programs among women who use illicit opioids in New York City. Paper presented at: 27th Harm Reduction International Conference; 2023 Apr 19. Melbourne (Australia).
- Hood JE, Banta-Green CJ, Duchin JS, Breuner J, Dell W, Finegood B, Glick SN, Hamblin M, Holcomb S, Mosse D, et al. Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: lessons learned from Seattle, Washington. Subst Abus. 2020;41:356–64. doi:10.1080/08897077.2019.1635557.
- Jakubowski A, Norton BL, Hayes BT, Gibson BE, Fitzsimmons C, Stern LS, Ramirez F, Guzman M, Spratt S, Marcus P, et al. Low-threshold buprenorphine treatment in a syringe services program: program description and outcomes. J Addict Med. 2022;16:447–53. doi:10.1097/ADM.0000000000000934.
- Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy. 2014;25:105–11. doi:10.1016/j.drugpo.2013.06.005.
- Dayton L, Tobin K, Falade-Nwulia O, Davey-Rothwell M, Al-Tayyib A, Saleem H, Latkin C. Racial disparities in overdose prevention among people who inject drugs. J Urban Health. 2020 Dec;97:823–30. doi:10.1007/s11524-020-00439-5.
- Beletsky L, Grau LE, White E, Bowman S, Heimer R. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs. Addiction. 2011 Feb;106:357–65. doi:10.1111/j.1360-0443.2010.03149.x.
- Morrissey B, Hughes T, Ostrach B, Wilson L, Getty R, Combs TL, Bennett J, Carroll JJ. “They don’t go by the law around here”: law enforcement interactions after the legalization of syringe services programs in North Carolina. Harm Reduct J. 2022;19:106. doi:10.1186/s12954-022-00690-w.
- Scheidell JD, Hoff L, Khan MR, Bennett AS, Elliott L. Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City. Drug Alcohol Depend Rep. 2022;3:100054. doi:10.1016/j.dadr.2022.100054.
- Coalition NHR. The Movement. [Accessed Apr, 2024]. https://harmreduction.org/movement/evolution/.
- Simon C, Brothers S, Strichartz K, Coulter A, Voyles N, Herdlein A, Vincent L. We are the researched, the researchers, and the discounted: the experiences of drug user activists as researchers. Int J Drug Policy. 2021 Dec;98:103364. doi:10.1016/j.drugpo.2021.103364.
- Beck McGreevy P, Wood S, Thomson E, Burmeister C, Spence H, Pelletier J, Giesinger W, McDougall J, McLeod R, Hutchison A, et al. Doing community-based research during dual public health emergencies (COVID and overdose). Harm Reduct J. 2023;20:135. doi:10.1186/s12954-023-00852-4.
- Salazar ZR, Vincent L, Figgatt MC, Gilbert MK, Dasgupta N. Research led by people who use drugs: centering the expertise of lived experience. Subst Abuse Treat Prev Policy. 2021;16:70. doi:10.1186/s13011-021-00406-6.
- Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N. Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. J Subst Abuse Treat. 2021 Apr;123:108276. doi:10.1016/j.jsat.2021.108276.